PATENT CLAIM ANALYSIS

Application Number: 15861974
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "182000"]

Abstract:
This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by administering estrogen, testosterone, precursors thereof or combinations thereof.

Claim (Index 9):
A method of treating an individual having Huntington's Disease (HD) or an individual having an HD gene having a number of CAG repeats greater than or equal to about 36; the method comprising:\n a. selecting the individual having HD; and b. administering to the individual an amount of estrogen or testosterone, wherein the amount of administration to an individual ranges from about 0.2 mg to about 10 mg of estrogen for a female individual or about 1 mg to about 35 g of testosterone for a male individual; wherein one or more symptoms associated with HD in the individual are reduced, as compared to the same in an individual with HD not subjected to step b.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12961250', '14334643', '11627978', '14961689', '13988605']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7467757277188104
- 35 USC 102 Novelty (BERT): 0.6347971355938411
- Combined Prediction Score: 0.7355778685063135
- Mean Citation Score: 394.770004
- Max Citation Score: 610.4043
- Similarity Product: 535.4665579641045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test